| Original language | English |
|---|---|
| Pages (from-to) | 14-30 |
| Number of pages | 17 |
| Journal | Journal of the National Cancer Institute |
| Volume | 110 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2018 |
Keywords
- POSITRON-EMISSION-TOMOGRAPHY
- RANDOMIZED PHASE-II
- CONTEXTUAL SYNTHETIC LETHALITY
- FSAIIC MURINE FIBROSARCOMA
- RADIATION ONCOLOGY GROUP
- EPIDERMAL-GROWTH-FACTOR
- CARBONIC-ANHYDRASE IX
- CONTRAST-ENHANCED-MRI
- EVERY 3 WEEKS
- TUMOR HYPOXIA
- NECK-CANCER
- RADIATION-THERAPY
- ACTIVATED PRODRUG
- OXYGEN-ENHANCED MRI
- PROGNOSTIC-SIGNIFICANCE
Cite this
}
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome. / Salem, Ahmed; Asselin, Marie-Claude; Reymen, Bart; Jackson, Alan; Lambin, Philippe; West, Catharine M. L.; O'Connor, James P. B.; Faivre-Finn, Corinne.
In: Journal of the National Cancer Institute, Vol. 110, No. 1, 01.01.2018, p. 14-30.Research output: Contribution to journal › Review article › Academic › peer-review
TY - JOUR
T1 - Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
AU - Salem, Ahmed
AU - Asselin, Marie-Claude
AU - Reymen, Bart
AU - Jackson, Alan
AU - Lambin, Philippe
AU - West, Catharine M. L.
AU - O'Connor, James P. B.
AU - Faivre-Finn, Corinne
PY - 2018/1/1
Y1 - 2018/1/1
KW - POSITRON-EMISSION-TOMOGRAPHY
KW - RANDOMIZED PHASE-II
KW - CONTEXTUAL SYNTHETIC LETHALITY
KW - FSAIIC MURINE FIBROSARCOMA
KW - RADIATION ONCOLOGY GROUP
KW - EPIDERMAL-GROWTH-FACTOR
KW - CARBONIC-ANHYDRASE IX
KW - CONTRAST-ENHANCED-MRI
KW - EVERY 3 WEEKS
KW - TUMOR HYPOXIA
KW - NECK-CANCER
KW - RADIATION-THERAPY
KW - ACTIVATED PRODRUG
KW - OXYGEN-ENHANCED MRI
KW - PROGNOSTIC-SIGNIFICANCE
U2 - 10.1093/jnci/djx160
DO - 10.1093/jnci/djx160
M3 - Review article
VL - 110
SP - 14
EP - 30
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
SN - 0027-8874
IS - 1
ER -